2021 Apr 20/21 - ACD | Bio-Techne Genomics Oncology Summit
Asmerom Sengal, MD, Ph.D.,
Postdoctoral Fellow Translational Research Institute (TRI), Australia
Watch Video:
Nallasivam Palanisamy, Ph.D.
Associate Scientist/Professor; Department of Urology, Henry Ford Health System USA
Lasse Sommer Kristensen, Ph.D.,
Associate Professor, Department of Biomedicine, Aarhus University, Denmark
Anushka Dikshit, Ph.D.,
Applications Scientist, Advanced Cell Diagnostics, a Bio-Techne Brand
Outline:
The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights into tumor immunology, the complex and heterogeneous tumor microenvironment and its dynamics in cancer initiation, progression, and metastasis. Using the different assays under the RNAscope technology umbrella, it is possible to simultaneously visualize and assess the gene expression of cytokines, chemokines, immune cell markers, tumor cell markers and checkpoint markers within the tumor microenvironment (TME).
Learning Objectives:
Learn how experts in the field of Oncology have utilized the RNAscope, BaseScope™ and Co-Detection Workflow Assays to address pertinent questions in their research.
The Bio-Techne Genomics Oncology Summit will be broadcast across three worldwide regions - Select your preferred Webinar Time in the registration form.
